top of page





The Asana Biosciences pipeline, focused on the therapeutic areas of oncology, inflammation and pain, was produced through effective application of a virtual, partnership-driven business model.


Asana will seek collaboration/out-licensing partners (global and territorial licensing agreements) for some of its development products upon completion of IND-enabling safety studies, Phase 1 or Phase 2 trials.  Selected partners will have expertise to contribute to the later stages of development and/or commercialization of the product, and to maximize the potential of the product. 


To learn more about how you might partner with Asana BioSciences, please contact us at

bottom of page